Free Trial

Insider Selling: Afya (NASDAQ:AFYA) CFO Sells 10,000 Shares of Stock

Afya logo with Consumer Discretionary background
Image from MarketBeat Media, LLC.

Key Points

  • CFO Luis Andre Carpintero Blanco sold 10,000 Afya shares on April 8 at an average price of $15.20 for a $152,000 transaction, reducing his stake by 16.37% to 51,103 shares (about $776,766).
  • Mixed financials and market reaction: Afya beat EPS estimates ($0.41 vs. $0.36) but missed revenue expectations ($147.08M vs. $174.74M), and the stock traded near $15.07 (down 1.1%); consensus rating is "Hold" with a $17.30 price target.
  • Dividend announced: Afya paid an annual dividend of $0.656 per share on April 6, with a reported payout ratio of 45.21%.
  • MarketBeat previews the top five stocks to own by May 1st.

Afya Limited (NASDAQ:AFYA - Get Free Report) CFO Luis Andre Carpintero Blanco sold 10,000 shares of Afya stock in a transaction on Wednesday, April 8th. The shares were sold at an average price of $15.20, for a total transaction of $152,000.00. Following the completion of the sale, the chief financial officer directly owned 51,103 shares of the company's stock, valued at approximately $776,765.60. The trade was a 16.37% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Afya Stock Down 1.1%

Shares of NASDAQ AFYA traded down $0.16 during mid-day trading on Friday, reaching $15.07. 110,572 shares of the company traded hands, compared to its average volume of 118,058. The company's fifty day moving average is $14.48 and its two-hundred day moving average is $14.70. Afya Limited has a fifty-two week low of $13.00 and a fifty-two week high of $19.90. The company has a debt-to-equity ratio of 0.41, a quick ratio of 2.20 and a current ratio of 2.20. The stock has a market cap of $1.41 billion, a PE ratio of 10.32, a price-to-earnings-growth ratio of 0.67 and a beta of 0.48.

Afya (NASDAQ:AFYA - Get Free Report) last announced its earnings results on Wednesday, March 11th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.36 by $0.05. Afya had a return on equity of 18.77% and a net margin of 20.31%.The firm had revenue of $147.08 million during the quarter, compared to analysts' expectations of $174.74 million. On average, analysts expect that Afya Limited will post 1.52 earnings per share for the current year.

Afya Announces Dividend

The company also recently announced an annual dividend, which was paid on Monday, April 6th. Shareholders of record on Wednesday, March 25th were given a dividend of $0.656 per share. The ex-dividend date of this dividend was Wednesday, March 25th. This represents a yield of 433.0%. Afya's payout ratio is currently 45.21%.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on AFYA shares. Bank of America downgraded Afya from a "buy" rating to a "neutral" rating and lowered their price target for the company from $22.00 to $17.00 in a research report on Tuesday, February 24th. Weiss Ratings restated a "hold (c)" rating on shares of Afya in a research note on Wednesday, January 21st. Zacks Research raised Afya from a "hold" rating to a "strong-buy" rating in a report on Tuesday. Wall Street Zen raised Afya from a "buy" rating to a "strong-buy" rating in a research report on Saturday, March 14th. Finally, Sanford C. Bernstein raised Afya to a "market perform" rating in a research report on Friday, January 16th. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, Afya currently has a consensus rating of "Hold" and a consensus price target of $17.30.

Get Our Latest Analysis on AFYA

Institutional Investors Weigh In On Afya

Several hedge funds have recently made changes to their positions in the stock. Van ECK Associates Corp lifted its stake in shares of Afya by 15.7% in the third quarter. Van ECK Associates Corp now owns 10,170 shares of the company's stock valued at $159,000 after buying an additional 1,377 shares during the period. Daiwa Securities Group Inc. acquired a new position in Afya in the 4th quarter valued at approximately $43,000. Arrowstreet Capital Limited Partnership lifted its position in shares of Afya by 5.6% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 68,169 shares of the company's stock worth $1,217,000 after acquiring an additional 3,626 shares during the period. Militia Capital Partners LP acquired a new stake in shares of Afya during the 2nd quarter worth approximately $71,000. Finally, Fairtree Asset Management Pty Ltd increased its position in shares of Afya by 22.3% during the fourth quarter. Fairtree Asset Management Pty Ltd now owns 30,697 shares of the company's stock valued at $473,000 after purchasing an additional 5,599 shares during the period. Institutional investors own 88.02% of the company's stock.

About Afya

(Get Free Report)

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya's offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.

Featured Articles

Insider Buying and Selling by Quarter for Afya (NASDAQ:AFYA)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Afya Right Now?

Before you consider Afya, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.

While Afya currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines